Abivax (STU:2X1) FFO


STU:2X1 Abivax SA STU:2X1
37 GF Score
Price €122.30
! 2 Warning Signs
View Full Analysis

What is Abivax FFO?

FFO (Funds from operations) only applies to REITs.

STU:2X1
37GF Score
Abivax SA STU:2X1
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abivax Business Description

Address 7-11 boulevard Haussmann, Paris, FRA, 75009
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.
37GF Score

Get the complete analysis for STU:2X1

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€122.30
Price